Search

Your search keyword '"Ong, Kai-ren"' showing total 282 results

Search Constraints

Start Over You searched for: Author "Ong, Kai-ren" Remove constraint Author: "Ong, Kai-ren"
282 results on '"Ong, Kai-ren"'

Search Results

3. The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource

4. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

5. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

6. Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service

7. The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.

8. The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource

9. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

10. The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers

11. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

12. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.

13. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.

14. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.

16. Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome

17. EP361/#717 Developing infrastructure for molecular profiling in ovarian cancer (DEMO)

18. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

19. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

20. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

22. 2022-RA-1058-ESGO Developing infrastructure for molecular profiling for all in ovarian cancer (DEMO)

23. Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

24. Prevalence and architecture of de novo mutations in developmental disorders

25. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2.

26. Whole-genome sequencing of patients with rare diseases in a national health system

27. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

28. Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language

29. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

30. The contribution of X-linked coding variation to severe developmental disorders

31. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT) : initial results from an international prospective study

32. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

33. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers:an international cohort study

34. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT):initial results from an international prospective study

35. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1and PALB2

37. Sporadic implementation of UK familial mammographic surveillance guidelines 15 years after original publication

38. Publisher Correction:Whole-genome sequencing of a sporadic primary immunodeficiency cohort (Nature, (2020), 583, 7814, (90-95), 10.1038/s41586-020-2265-1)

39. Whole-genome sequencing of a sporadic primary immunodeficiency cohort

40. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

41. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

42. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

43. Interim Results from the IMPACT Study:Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

44. Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes

45. Bayesian Inference Associates Rare KDR Variants With Specific Phenotypes in Pulmonary Arterial Hypertension

46. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

47. Prostate Cancer Risk by BRCA2 Genomic Regions

48. P024: Genetics and pathological features of breast cancer in patients of non-caucasian origin - Reference genetics centre laboratory results

49. Abstract P2-10-13: Genetics and pathological correlation of BRCA status in patients of Asian origin diagnosed with breast or ovarian cancer; a UK Reference Genetics Laboratory Study

50. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

Catalog

Books, media, physical & digital resources